No Data
No Data
Subdued Growth No Barrier To Shanghai Runda Medical Technology Co., Ltd.'s (SHSE:603108) Price
2024 Semi-Annual Report
2024 Semi-Annual Report Summary
Shanghai Runda Medical Technology (603108.SH): The net income for the first half of the year was 91.3061 million yuan, a year-on-year decrease of 47.82%.
Shanghai Runda Medical Technology (603108.SH) released its semi-annual report on August 28. During the reporting period, the company achieved a total revenue of 4.135 billion yuan, a decrease of 8.54% compared to the same period last year. This is mainly due to the impact of the medical policy environment during the reporting period, which has affected the development of customers in various levels of medical institutions and led to a slight decrease in the company's business revenue compared to the same period last year. The company's net income attributable to shareholders during the reporting period was 91.3061 million yuan, a decrease of 47.82% compared to the same period last year. This is mainly due to the decrease in operating income during the reporting period, while the company's gross margin remained stable and fixed expenses such as personnel remained unchanged.
Is Shanghai Runda Medical Technology Co., Ltd.'s (SHSE:603108) 6.7% ROE Strong Compared To Its Industry?
Shanghai Runda Medical Technology Co., Ltd. (SHSE:603108) Is About To Go Ex-Dividend, And It Pays A 0.8% Yield
No Data
No Data